药学与临床研究2024,Vol.32Issue(2) :149-153.

妊娠期肝内胆汁淤积症患者的肠道菌群变化及微生物疗法的研究进展

Changes of Intestinal Flora in Patients with Intrahepatic Cholestasis of Pregnancy and Progress of Microbial Therapy

郭小慧 梅洪梁 张源 张海霞
药学与临床研究2024,Vol.32Issue(2) :149-153.

妊娠期肝内胆汁淤积症患者的肠道菌群变化及微生物疗法的研究进展

Changes of Intestinal Flora in Patients with Intrahepatic Cholestasis of Pregnancy and Progress of Microbial Therapy

郭小慧 1梅洪梁 2张源 1张海霞2
扫码查看

作者信息

  • 1. 南京大学医学院附属鼓楼医院药学部,南京 210008;中国药科大学基础医学与临床药学学院,南京 210009
  • 2. 南京大学医学院附属鼓楼医院药学部,南京 210008;南京临床药学中心,南京 210008
  • 折叠

摘要

妊娠期肝内胆汁淤积症(ICP)是一种多发于妊娠晚期的疾病,严重影响着母婴结局,其病因和发病机制目前尚不清楚.血清胆汁酸水平是ICP诊断的主要临床依据,肠道菌群在胆汁酸的合成和代谢中起关键作用,肠道菌群及其代谢产物与ICP密切相关.微生物疗法如益生菌的使用可改善肠道微生物群,可作为治疗ICP的新思路.本文就ICP患者胆汁酸变化与肠道菌群之间的关系进行综述,分析肠道菌群与ICP发生发展的关系,发现某些特定菌种(如大肠杆菌志贺菌属、拟杆菌、双歧杆菌以及乳酸杆菌等)与ICP的发展密切相关,并总结益生菌改善胆汁淤积的研究进展,以期为ICP的临床治疗和管理提供新思路.

Abstract

Intrahepatic cholestasis of pregnancy(ICP)frequently manifests in late pregnancy,significantly impacts the well-being of both mothers and infants.Its etiology andi pathogenesis remain unclear.The diagnosis of ICP primarily relies on serum bile acid levels.Intestinal flora significantly contributes to the synthesis and metabolism of bile acids,and both intestinal flora and its metabolites are closely associated with ICP.Microbiological interventions,including probiotic usage,can enhance the intestinal flora,presenting a novel approach for ICP treatment.In this paper,we reviewed the association between bile acid alterations and intestinal flora in ICP patients,analyzed the correlation between intestinal flora and ICP development,and found that specific bacterial strains(e.g.,Escherichia/Shigella,Bacteroides,Bifidobacterium and Lactobacillus)closely linked to ICP development.Additionally,we summarized the advancements in research on probiotic utilization to ameliorate the cholestatic process,aming to enhance comprehension of ICP and offer fresh perspectives for its clinical treatment and management.

关键词

妊娠期肝内胆汁淤积症/肠道菌群/益生菌/研究进展

Key words

Intrahepatic cholestasis of pregnancy/Intestinal flora/Probiotics/Research progress

引用本文复制引用

基金项目

江苏省药学会-恒瑞医院药学基金科研项目(H202107)

南京药学会-常州四药医院药学科研基金(2021YX004)

国家自然科学基金(81903870)

出版年

2024
药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子:0.95
ISSN:1673-7806
参考文献量45
段落导航相关论文